| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
8-K: Regulation FD Disclosure
On November 16, 2026, MiniMed Group, Inc. (“MiniMed”) announced that the U.S. Food and Drug Administration (the “FDA”) has cleared the MiniMed Fit™ patch pump, MiniMed’s first tubeless insulin pump, offering people with diabetes a new di... |
| 16 Oct 2026 |
8-K: Changes in Control of Registrant; Departure/Election of Directors or Officers; Compensation +1 more
NORTHRIDGE, Calif., October 15, 2026 – MiniMed (Nasdaq: MMED) today announced the completion of its separation from Medtronic plc (“Medtronic”; NYSE: MDT), marking its first day as a fully independent company. |
| 13 Oct 2026 |
8-K: Submission of Matters to a Vote of Security Holders
MiniMed Group, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders on October 9, 2026 (the “Annual Meeting”), at which stockholders voted on the following four proposals. All matters voted on at the Annual Meeting were appr... |
| 01 Sep 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration |
| 05 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 29 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Shareholder Director Nominations +1 more
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 03 Jun 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook |
| 18 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 27 Apr 2026 |
8-K: Regulation FD Disclosure
On April 24, 2026, Medtronic plc (“Medtronic”), the parent company of MiniMed Group, Inc. (“MiniMed”), announced that an unauthorized third party had accessed data in certain of Medtronic’s information technology (“IT”) systems. In its r... |
| 27 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On March 23, 2026, the Compensation and Talent Committee (the “Committee”) of the Board of Directors of MiniMed Group, Inc. (the “Company”) approved the MiniMed Severance Pay Plan for Executives (the “Severance Plan”) and applicable seve... |
| 25 Mar 2026 |
8-K: Regulation FD Disclosure
On March 18, 2026, MiniMed Group, Inc. (“MiniMed”) announced that the U.S. Food and Drug Administration (the “FDA”) has cleared the MiniMed Flex™, a next-generation discreet, smartphone-controlled insulin pump. The clearance of the MiniM... |
| 09 Mar 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more
This SEPARATION AGREEMENT, dated as of March 1, 2026, by and between (i) Medtronic Group Holding, Inc., a Minnesota corporation (“Medtronic”) and (ii) Kangaroo US HoldCo 2, Inc., a Delaware corporation (prior to the SplitCo Merger (as de... |
Loading...